Search Results - "Bogers, Jan"

Tapering antipsychotic medication: practical considerations by Horowitz, Mark A, Moncrieff, Joanna, de Haan, Lieuwe, Bogers, Jan P A M, Gangadin, Shiral S, Kikkert, Martijn, Veling, Wim, Sommer, Iris E C

Get more information

Beyond White Blood Cell Monitoring: Screening in the Initial Phase of Clozapine Therapy by COHEN, Dan, BOGERS, Jan P. A. M, DIJK, Daniel Van, BAKKER, Bert, SCHULTE, Peter F. J

“…Clozapine is the preferred option for treatment-resistant schizophrenia. However, since 1975, clozapine has been known to cause agranulocytosis. In the…”
Get full text

Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring: Can the regulations be relaxed? by Schulte, Peter F.J., Veerman, Selene R.T., Bakker, Bert, Bogers, Jan P.A.M., Jongkind, Amy, Cohen, Dan

“…After the introduction of clozapine eight Finnish patients died after developing agranulocytosis. Clozapine was withdrawn from the market and only reintroduced…”
Get full text

Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials by Bogers, Jan P A M, Hambarian, George, Walburgh Schmidt, Niels, Vermeulen, Jentien M, de Haan, Lieuwe

“…Although maintenance treatment with antipsychotics protects against psychotic relapse, high doses may hamper recovery. Therefore, dose reduction or…”
Get full text

Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma by van der Heide, Douwe H., Bogers, Jan P.A.M., Schulte, Peter (Raphael) F.J.

Get full text

Clozapine and COVID‐19 Vaccination: Effects on blood levels and leukocytes. An observational cohort study by Veerman, Selene R. T., Moscou, Timo, Bogers, Jan P. A. M., Cohen, Dan, Schulte, Peter F. J.

“…Objective To investigate the safety of COVID‐19 vaccination in patients on clozapine as regards plasma clozapine concentration and haematological parameters…”
Get full text

Capillary compared to venous blood sampling in clozapine treatment: patients׳ and healthcare practitioners׳ experiences with a point-of-care device by Bogers, Jan P.A.M, Bui, Hong, Herruer, Martien, Cohen, Dan

“…Abstract Underuse of the antipsychotic clozapine for schizophrenia is an impediment to improving outcomes for patients. Because of its possible severe side…”
Get full text

Feasibility and Effect of Increasing Clozapine Plasma Levels in Long-Stay Patients With Treatment-Resistant Schizophrenia by Bogers, Jan P.A.M., Schulte, Peter F.J., Broekman, Theo G., de Haan, Lieuwe

“…It is unknown whether increasing the clozapine plasma level to 400, 750, or even 1000 ng/mL is a feasible and effective strategy in patients with…”
Get full text

COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine by Veerman, Selene R T, Bogers, Jan P A M, Cohen, Dan, Schulte, Peter F J

“…The Dutch Clozapine Collaboration Group is frequently asked for advice about the management of clozapine-treated patients when infected with or vaccinated…”
Get more information

Clozapine Underutilization in the Treatment of Schizophrenia: How Can Clozapine Prescription Rates Be Improved? by Bogers, Jan P A M, Schulte, Peter F J, Van Dijk, Daniel, Bakker, Bert, Cohen, Dan

Get full text

Cognitive Effects of Reducing First-Generation Antipsychotic Dose Compared to Switching to Ziprasidone in Long-Stay Patients with Schizophrenia by Bogers, Jan P A M, Blömer, Jasper A, de Haan, Lieuwe

“…Cognitive impairment is a core symptom of schizophrenia and is associated with functional outcomes. Improving cognitive function is an important treatment…”
Get full text

Interaction of St John’s wort (Hypericum perforatum) with clozapine by Van Strater, Annelies C.P, Bogers, Jan P.A.M

“…St John’s wort (Hypericum perforatum) is notorious for its ability to induce the enzymes of the P450 system. Especially, it induces CYP1A2 and CYP3A4, enzymes…”
Get full text

Oral contraceptives raise plasma clozapine concentrations by Bookholt, Dorinde E, Bogers, Jan P A M

Get full text

Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial by Bogers, Jan P.A.M., Schulte, Peter F.J., Broekman, Theo G., Moleman, Peter, de Haan, Lieuwe

“…Long-stay patients with severe schizophrenia are frequently treated with high doses of first-generation antipsychotics (FGA). Dose reduction or switching to…”
Get full text

The incidence and economic impact of aggression in closed long-stay psychiatric wards by de Bles, Nienke J., Hazewinkel, Andreia W. P., Bogers, Jan P. A. M., van den Hout, Wilbert B., Mouton, Constant, van Hemert, Albert M., Rius Ottenheim, Nathaly, Giltay, Erik J.

“…Aggressive behaviour is highly prevalent in long-term psychiatric inpatient care. We aimed to estimate the overall incidence of aggression, the time staff took…”
Get full text

Effects of multivitamin, mineral and n-3 polyunsaturated fatty acid supplementation on aggression among long-stay psychiatric in-patients: randomised clinical trial by de Bles, Nienke J., Rius-Ottenheim, Nathaly, Geleijnse, Johanna M., van de Rest, Ondine, Bogers, Jan P.A.M., Schat, Anke, Nijman, Henk L.I., van den Berg, David, Joos, Lucas, van Strater, Annelies, de Ridder, Tine, Stolker, Joost J., van den Hout, Wilbert B., van Hemert, Albert M., Giltay, Erik J.

“…Aggression and violent incidents are a major concern in psychiatric in-patient care. Nutritional supplementation has been found to reduce aggressive incidents…”
Get full text

Low levels of vitamin D poorly responsive to daylight exposure in patients with therapy-resistant schizophrenia by Bogers, Jan P. A. M., Bostoen, Tijmen, Broekman, Theo G.

“…Background: Low vitamin D levels are associated with schizophrenia, but the possible association between vitamin D levels and illness severity or duration of…”
Get full text

Clozapine and the risk of haematological malignancies by Schulte, Peter FJ, Cohen, Dan, Veerman, Selene RT, Bakker, Bert, Bogers, Jan PAM

Get full text

Differences between physicians' and nurse practitioners' viewpoints on reasons for clozapine underprescription by Okhuijsen‐Pfeifer, Cynthia, Cohen, Dan, Bogers, Jan P. A. M., Vos, Cato M. H., Huijsman, Elianne A. H., Kahn, René S., Luykx, Jurjen J.

“…Introduction Clozapine (CLZ) is the only proven effective therapy for treatment‐resistant schizophrenia, but it is underutilized across the globe. Previous…”
Get full text

Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts by Gillespie, Amy L., Walker, Emma M., Hannon, Eilis, McQueen, Grant A., Sendt, Kyra-Verena, Avila, Alessia, Lally, John, Okhuijsen-Pfeifer, Cynthia, van der Horst, Marte, Hasan, Alkomiet, Dempster, Emma L., Burrage, Joe, Bogers, Jan, Cohen, Dan, Boks, Marco P., Collier, David A., Egerton, Alice, Luykx, Jurjen J., Mill, Jonathan, MacCabe, James H.

“…The second-generation antipsychotic clozapine is used as a medication for treatment-resistant schizophrenia. It has previously been associated with epigenetic…”
Get full text